Insider trading

Period: 120 months Stock: EWTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

123 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

123 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

123 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

123 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
123 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
123 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

123 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 May 2024
Derakhshan Behrad Chief Business Officer
Sold at will
$32.49K 1,718 at 18.91
11.3%
Not planned
2 May 2024
Russell Alan J Chief Scientific Officer
Sold at will
$29.80K 1,576 at 18.91
17.9%
Not planned
9 Feb 2024
MOORE JOHN R General Counsel
Sold on a plan
$160.66K 8,029 at 20.01
100%
Sold half or more
9 Feb 2024
Derakhshan Behrad Chief Business Officer
Sold on a plan
$96.21K 4,800 at 20.04
40.6%
Planned (10b5-1)
8 Feb 2024
Derakhshan Behrad Chief Business Officer
Sold on a plan
$92.05K 4,600 at 20.01
39.6%
Planned (10b5-1)
8 Feb 2024
MOORE JOHN R General Counsel
Sold on a plan
$76.28K 3,813 at 20.01
100%
Sold half or more
7 Feb 2024
MOORE JOHN R General Counsel
Sold on a plan
$359.86K 17,993 at 20.00
100%
Sold half or more
7 Feb 2024
Derakhshan Behrad Chief Business Officer
Sold on a plan
$12.00K 600 at 20.00
7.9%
Planned (10b5-1)
23 Jan 2024
Thompson Peter A. Director · indirect
Bought
$5.00M 454,545 at 11.00
3.3%
23 Jan 2024
ORBIMED ADVISORS LLC Director · indirect
Bought
$5.00M 454,545 at 11.00
3.3%
23 Jan 2024
Carruthers R Michael Chief Financial Officer
Sold on a plan
$1.42M 90,000 at 15.78
75.6%
Sold half or more
27 Dec 2023
MOORE JOHN R General Counsel
Sold at will
$89.22K 8,497 at 10.50
100%
Sold half or more
26 Dec 2023
Russell Alan J Chief Scientific Officer
Sold at will
$1.61M 172,585 at 9.33
98.0%
Sold half or more
26 Dec 2023
Fox Jonathan C Director
Bought
$100.96K 10,857 at 9.30
opened
First buy on file
2 May 2023
Sold at will
$28.98K 3,254 at 8.90
24.6%
Not planned
2 May 2023
KOCH KEVIN President and CEO
Sold at will
$28.52K 3,203 at 8.90
30.8%
Not planned
2 May 2023
MOORE JOHN R General Counsel
Sold at will
$16.89K 1,897 at 8.90
22.4%
Not planned
2 May 2023
Derakhshan Behrad Chief Business Officer
Sold at will
$15.56K 1,747 at 8.90
19.9%
Not planned
2 May 2023
Russell Alan J Chief Scientific Officer
Sold at will
$14.27K 1,602 at 8.90
0.9%
Not planned
2 May 2023
Carruthers R Michael Chief Financial Officer
Sold at will
$11.90K 1,336 at 8.90
7.7%
Not planned
3 Oct 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$46.15K 4,730 at 9.76
61.2%
Sold half or more
16 Sep 2022
Thompson Peter A. Director · indirect
Bought
$5.00M 484,496 at 10.32
3.6%
16 Sep 2022
ORBIMED ADVISORS LLC Director · indirect
Bought
$5.00M 484,496 at 10.32
3.6%
14 Sep 2022
Novo Holdings A/S 10% owner
Bought
$5.00M 484,496 at 10.32
8.7%
6 Sep 2022
MOORE JOHN R General Counsel
Sold, plan not stated 2×
$51.60K 4,730 at 10.91
61.2%
Sold half or more
3 Aug 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$85.92K 9,232 at 9.31
75.5%
Sold half or more
6 Jul 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$8.93K 1,046 at 8.54
25.9%
5 Jul 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$68.33K 8,186 at 8.35
73.2%
Sold half or more
21 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$226.70K 31,078 at 7.29
91.2%
Sold half or more
17 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$146.43K 22,127 at 6.62
88.1%
Sold half or more
16 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$90.81K 14,722 at 6.17
83.1%
Sold half or more
15 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated 2×
$114.02K 18,660 at 6.11
86.1%
Sold half or more
14 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$21.85K 3,628 at 6.02
54.7%
Sold half or more
13 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$24.58K 4,093 at 6.01
57.7%
Sold half or more
10 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$43.12K 7,125 at 6.05
70.4%
Sold half or more
9 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$49.40K 7,615 at 6.49
71.7%
Sold half or more
8 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$83.36K 12,566 at 6.63
80.7%
Sold half or more
7 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated 2×
$119.70K 18,123 at 6.61
85.8%
Sold half or more
6 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$84.08K 13,934 at 6.03
82.3%
Sold half or more
3 Jun 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$92.20K 15,230 at 6.05
83.5%
Sold half or more
18 May 2022
ORBIMED ADVISORS LLC Director · indirect
Bought
$994.98K 138,000 at 7.21
1.0%
18 May 2022
Thompson Peter A. Director · indirect
Bought
$994.98K 138,000 at 7.21
1.0%
16 May 2022
MOORE JOHN R General Counsel
Sold, plan not stated
$80.15K 10,800 at 7.42
78.3%
Sold half or more
15 Nov 2021
Russell Alan J Chief Scientific Officer
Sold, plan not stated 2×
$9.16K 479 at 19.11
100%
Sold half or more
12 Nov 2021
Russell Alan J Chief Scientific Officer
Sold, plan not stated
$167.07K 8,562 at 19.51
94.7%
Sold half or more
11 Nov 2021
Russell Alan J Chief Scientific Officer
Sold, plan not stated 2×
$384.24K 19,276 at 19.93
68.1%
Sold half or more
10 Nov 2021
Russell Alan J Chief Scientific Officer
Sold, plan not stated 2×
$243.17K 12,326 at 19.73
30.3%
9 Nov 2021
Russell Alan J Chief Scientific Officer
Sold, plan not stated 2×
$594.31K 29,576 at 20.09
42.1%
8 Nov 2021
Russell Alan J Chief Scientific Officer
Sold, plan not stated
$181.82K 9,017 at 20.16
11.4%
5 Nov 2021
Russell Alan J Chief Scientific Officer
Sold, plan not stated 2×
$255.91K 13,042 at 19.62
14.1%
Showing 51–100 of 123. ← Newer Page 2 of 3 Older →